Details for Patent: 10,669,546

Which drugs does patent 10,669,546 protect, and when does it expire?

Patent 10,669,546 protects QALSODY and is included in one NDA.

This patent has fifty-six patent family members in twenty-five countries.

Summary for Patent: 10,669,546

Title:	Compositions for modulating SOD-1 expression
Abstract:	Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).
Inventor(s):	Swayze Eric E.
Assignee:	Biogen MA Inc.
Application Number:	US16513297
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,669,546

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Biogen Ma	QALSODY	tofersen	SOLUTION;INTRATHECAL	215887-001	Apr 25, 2023		RX	Yes	Yes						TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) IN ADULTS WHO HAVE A MUTATION IN THE SUPEROXIDE DISMUTASE 1 (SOD1) GENE

International Family Members for US Patent 10,669,546

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015240761
Australia	2019268063
Australia	2022200002
Brazil	112016021848